Jam

Premium Catering reported S$2.23 million in revenue and a net loss of S$1.40 million for the six months ending December 31, 2024. This contrasts with revenues of S$2.83 million and a loss of S$455,890 for the same period in 2023.

Chrysler celebrates its 100th anniversary with a “Century of Innovation” social media video series. The seven-part series explores Chrysler’s history, including trailblazers like Walter P. Chrysler, iconic vehicles, and technological advancements. The brand is commemorating the centennial with events like an employee gathering and the reveal of the 2026 Pacifica 100th Anniversary Edition, promising more announcements throughout the summer.

ImmunoPrecise Antibodies (IPA) announced a breakthrough in dengue vaccine development using its LENS^ai platform, powered by HYFT technology. The platform identified a conserved epitope across all dengue serotypes, paving the way for a universal vaccine. IPA plans to expand its AI-driven approach to other infectious diseases and oncology, streamlining vaccine development and potentially reducing costs. This discovery highlights AI’s potential to address complex challenges in biology.

Duluth Trading Company reported Q1 2025 results, with net sales of $102.7 million and a net loss of $15.3 million. New leadership is focused on streamlining operations and optimizing costs. Initiatives include brand focus and product portfolio review. The company reaffirms its 2025 financial guidance.

P2P Group Ltd. partners with PQStation, a quantum-resilient cybersecurity leader, to secure critical infrastructure, targeting markets in the US, Canada, and Europe. The collaboration integrates QSTunnel, a post-quantum cryptographic platform, enabling quantum-safe encryption deployment. This initiative addresses growing regulatory demands and military adoption of quantum-safe standards, aiming to equip Wi-Fi networks and chipsets with enhanced security for various sectors while projecting significant revenue growth over three years.

SWZ (formerly The Swiss Helvetia Fund) underwent a strategic shift in February 2025, embracing a total return objective under Bulldog Investors. The $92.4 million portfolio, as of May 2025, now includes Swiss, U.S., and a significant cash component (50.3%). A $3.00 special dividend was distributed in April. The fund’s performance reflecting its new strategy will be closely watched.

Celanese Corporation (CE) will participate in the Deutsche Bank Global Industrials and Materials Conference. President and CEO Scott Richardson will present a fireside chat on June 5, 2025, at 11:50 AM ET. A live webcast and replay (available for a year) will be accessible on the Celanese Investor Relations website. Celanese is a global specialty materials and chemicals leader, employing over 11,000 people and with $10.3 billion in 2024 net sales.

Helius Medical Technologies has priced its public offering, offering 2,768,600 shares of Class A common stock equivalents with warrants for an additional 2,768,600 shares at $3.27 per unit. Warrants have a 2.5-year lifespan and an initial exercise price of $7.35. The offering is expected to close June 6, 2025, with gross proceeds of $9.1 million. Maxim Group LLC is the placement agent.

HUTCHMED and Innovent Biologics announced the NMPA acceptance of a New Drug Application for fruquintinib and sintilimab combination therapy. This targets advanced renal cell carcinoma patients who failed prior tyrosine kinase inhibitor treatment. Based on positive FRUSICA-2 trial results, it met its primary endpoint of progression-free survival. The therapy may address the unmet needs for second-line treatment, with ongoing research to expand its applications and indications in immuno-oncology.

Targa Resources Corp. announced a $1.5 billion senior notes offering, comprising notes due 2030 and 2036. Proceeds will redeem existing 2027 notes and be used for general corporate purposes, providing financial flexibility. The offering is under an effective shelf registration with the SEC, and the deal is expected to close June 18, 2025.